Elsa LaVita

Senior Director, Patient Advocacy Cullinan Therapeutics

Seminars

Wednesday 6th May 2026
Roundtable: Scaling Patient Engagement Measurement in Biotech Without Big- Pharma Resources
2:30 pm
  • Prioritizing high-value metrics that matter to leadership, partners, and regulators
  • Embedding lightweight tracking into existing workflows to avoid measurement fatigue
  • Leveraging outsourced partners, CROs, and patient groups to extend capacity
  • Preparing early-stage measurement foundations that scale as the organization grows
  • Tracking the long-term benefits of patient engagement to demonstrate value to the organization over time
Elsa Lavita, Senior Director of Patient Advocacy at Cullinan Therapeutics, speaking at 3rd Measuring Patient Engagement Conference